drugset / Trial / NCT04699175

A Trial of HR021618 in Postsurgical Pain Management

NCT04699175 ↗

Phase 2 Unknown 108 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy, safety of HR021618 and to explore the reasonable dosage of HR021618 for Pain Management after Orthopaedic surgery.

Timeline

Start
2020-12-17
Primary completion
2021-08-03
Completion
2021-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject HR021618 Unknown — —

Indications

No indication recorded.